Aptatek BioSciences, Inc.
PrivateLast Round
Early Funding
Sep 29, 2026
Total Funding Raised
$4M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Aptatek BioSciences, Inc. is a medical technology company that develops portable, aptamer-based diagnostic devices for the home monitoring of chronic diseases such as phenylketonuria.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptatek BioSciences, Inc. Comparables
Compare Aptatek BioSciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| In Vitro Diagnostic Solutions | 92% | |
| Allworth Diagnostics | 89% | |
| Kilele Health Inc. | 85% |
Aptatek BioSciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 29, 2026 | ||||
| Convertible Debt | Jun 11, 2025 | ||||
| Seed | Jun 18, 2024 | ||||
| Seed | Mar 16, 2022 |
Aptatek BioSciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Seed |
| Longview Innovation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2026
Led by Longview Innovation and Canterbury Scientific.
- Aug 21, 2026
Monthly visitors grew 201% MoM, reaching 2.2K.
Aptatek BioSciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aptatek BioSciences, Inc.'s valuation, stock price, and market status.
Is Aptatek BioSciences, Inc. a public or private company?
Aptatek BioSciences, Inc. is a private company.
What is the current stock price of Aptatek BioSciences, Inc.?
Aptatek BioSciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Aptatek BioSciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aptatek BioSciences, Inc. worth (valuation)?
Valuation information for Aptatek BioSciences, Inc. is not publicly available.
Can I buy Aptatek BioSciences, Inc. stock?
Aptatek BioSciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aptatek BioSciences, Inc.'s last funding round?
Aptatek BioSciences, Inc.'s most recent funding round was Early Funding on September 29, 2026.
Who are the main investors in Aptatek BioSciences, Inc.?
Key investors in Aptatek BioSciences, Inc. include IP Group, Longview Innovation.
Will Aptatek BioSciences, Inc. IPO soon?
No public IPO plans have been announced for Aptatek BioSciences, Inc..
How can I track Aptatek BioSciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Aptatek BioSciences, Inc.'s shares on secondary markets.